カテゴリ： GlobalData, スウェーデン, 企業調査

Getinge AB (GETI B)-医療機器分野：企業M&A・提携分析

◆英語タイトル：Getinge AB (GETI B) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA8011732
◆発行会社（調査会社）：GlobalData
◆発行日：2017年12月13日
◆ページ数：94
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：スウェーデン
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Getinge AB (Getinge) is a global medical technology company that designs, develops and markets equipment and instruments in the areas of surgery, infection control, intensive care, care ergonomics and wound care. Its major products include surgical tables, lights, ventilators and anesthesia equipment, heart-lung machines with accompanying disposables, equipment and instruments for cardiac surgery, vascular surgery; cardiac assist devices; patient lifting devices, hospital beds, stretchers and couches, mattresses for treating and preventing pressure sores, disinfectors, sterilization equipment, and documentation (IT) systems and accessories. The company has manufacturing facilities in various parts of the world and sells its products through proprietary sales companies and a net work of distributors the world over. Getinge is headquartered in Vastra Gotaland, Sweden.

Getinge AB (GETI B) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 6
Getinge AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Getinge AB, Medical Equipment Deals By Type, 2011 to YTD 2017 9
Getinge AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Getinge AB, Medical Equipment, Deals By Market, 2011 to YTD 2017 11
Getinge AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Getinge AB, Medical Equipment, Deal Details 14
Asset Purchase 14
Kinetic Concepts Completes Sale Of Therapeutic Support Systems Business To Getinge For US$275 Million 14
Maquet Cardiopulmonary Completes Acquisition Of Avalon Elite Bi-Caval Dual Lumen Catheter And Vascular Access Kits From Avalon Labs For US$9.5 Million 16
Partnerships 18
Getinge Enters into Co-Development Agreement with Verb Surgical 18
Getinge Enters into Co-Distribution Agreement with Contego Medical 19
Getinge Enters into Distribution Agreement with Ultra Clean Systems 20
Maquet Medical Systems Enters into Distribution Agreement with Biotronik 21
Maquet Medical Systems Enters into Distribution Agreement with ReFlow Medical 22
Getinge Infection Control Enters into Distribution Agreement with TSO3 23
Maquet Enters into Co-Development Agreement with GE Healthcare 24
Maquet Medical Systems Enters into Agreement with Flight Medical 25
Maquet Medical Systems Extends Distribution Agreement with ClearFlow 26
Maquet Medical Systems Enters into Distribution Agreement with InterValve 27
Pulsion Enters Into Agreement With Maquet For Eirus Continuous Glucose And Lactate Monitoring Solution 28
Maquet Enters Into Distribution Agreement With Swisstom For Swisstom BB2 29
Proxy Biomedical Enters Into Distribution Agreement With Maquet Vascular Systems 30
Richard Wolf Medical Enters Into Agreement With Maquet For Operating Room Integration Solutions 31
Ossur Enters into Distribution Agreement with ArjoHuntleigh 32
Soma Technology Enters Into Agreement With Maquet 33
Maquet Enters Into Co-Marketing Agreement With Aesculap For OR Integration Solutions 34
Maquet Enters Into Technology Integration Agreement With Richard Wolf 35
Siemens Healthcare Enters Into Technology Integration Agreement With MAQUET For Hybrid OR 36
Novadaq Technologies Enters Into Distribution Agreement With MAQUET Cardiovascular 37
StaminaLift Enters into Distribution Agreement with ArjoHuntleigh 38
Equity Offering 39
Getinge Raises USD533.4 Million in Rights Offering of Shares 39
Debt Offering 41
Getinge Completes Public Offering Of Floating Rate Notes For US$140 Million 41
Acquisition 42
Getinge Acquires Cetrea 42
Getinge Plans to Acquire Additional Stake in Pulsion Medical Systems 43
Getinge Completes Acquisition Of 78.55% Stake In Pulsion Medical Systems For US$148.5 Million 44
Maquet Cardiovascular Acquires LAAx, Developer Of Cardiovascular Surgery Device 46
ArjoHuntleigh Completes Acquisition of Acare Medical Science for USD25.6 Million 47
MAQUET Cardiovascular Completes Acquisition Of Atrium Medical For US$680 Million 48
Getinge AB – Key Competitors 49
Getinge AB – Key Employees 50
Getinge AB – Locations And Subsidiaries 51
Head Office 51
Other Locations & Subsidiaries 51
Recent Developments 55
Strategy And Business Planning 55
Jun 29, 2017: Visit Our New Hybrid Operating Room at Getinge Experience Center 55
Oct 18, 2016: Further developed and focused strategy, and preparation for distribution of Patient & Post-Acute Care to shareholders of Getinge 56
Financial Announcements 57
Oct 18, 2017: Getinge publish Interim Report January – September 2017 57
Jul 17, 2017: Getinge: Interim Report January – June 2017 58
Apr 25, 2017: Getinge: Interim Report January-March 2017 59
Jan 26, 2017: Getinge Year-End Report January-December 2016 60
Oct 18, 2016: Getinge Interim Report January-September 2016 61
Jul 14, 2016: Getinge Interim Report January-June 2016 64
Apr 22, 2016: Getinge Interim Report January-March 2016 65
Jan 28, 2016: Getinge Group Year-End Report 2015 67
Corporate Communications 68
Sep 26, 2017: Getinge Appoints Interim CFO 68
Jul 17, 2017: Getinge appoints Lars Sandstrom as CFO and Member of Getinge Executive Team 69
Apr 20, 2017: Chief Financial Officer leaves Getinge 70
Mar 29, 2017: Resolutions at Getinge’s Annual General Meeting 2017 71
Nov 03, 2016: Mattias Perjos appointed President and CEO of Getinge Group 72
Sep 13, 2016: Getinge Group appoints Reinhard Mayer as new CFO and Magnus Lundbäck as new Executive Vice President Human Resources & Sustainability 73
Aug 22, 2016: Replacement of President & CEO Getinge Group:Joacim Lindoff appointed Acting President & CEO of Getinge Group 74
Jun 03, 2016: Getinge Group appoints Jens Viebke as new President of Acute Care Therapies Business Category Unit 75
Legal and Regulatory 76
Jul 17, 2017: Getinge has replanned the remediation in Hechingen (DE) related to the Consent Decree with FDA and makes a provision of additional SEK 488 M 76
Jun 24, 2017: Investigation by the Brazilian Administrative Council for Economic Defense comprises two Getinge entities 77
Government and Public Interest 78
Mar 20, 2017: Getinge establishes new brand structure and becomes a single brand company 78
Product News 79
Oct 03, 2017: Getinge announces its continued commitment to the European Association for Cardio-Thoracic Surgery Annual Meeting 79
Oct 02, 2017: Getinge announces its continued commitment to the World Federation for Hospital Sterilization Sciences Congress 80
Sep 22, 2017: Getinge announces its continued commitment to the European Society of Intensive Care Medicine 81
Jun 16, 2017: Datascope /MAQUET Issues Worldwide Voluntary Recall of the System CS100, CS100i and CS300 Intra-Aortic Balloon Pumps for Potential Electrical Test Failure Code 82
Mar 21, 2017: The new Getinge logo – inspired by the star of life 83
Mar 15, 2017: Getinge to exhibit full product portfolio for Intensive Care Units at International Symposium on Intensive Care and Emergency Medicine (ISICEM) 84
Jan 15, 2017: Getinge Group to exhibit complete product portfolio at Arab Health 85
Other Significant Developments 86
Nov 20, 2017: Getinge installs its 1,000th Hybrid operating room 86
Nov 10, 2017: Revised strategy, new financial targets and restated financial information for Getinge (excluding Arjo) 87
Aug 03, 2017: Getinge to cooperate with Brazilian authorities on local ongoing investigations 89
Jun 27, 2017: New Hybrid Operating Room in Getinge Experience Center, Germany 90
Feb 10, 2017: Getinge Group Announces Partnership with Ultra Clean Systems to Distribute Portfolio of Ultrasonic Cleaning Systems in U.S. and Canada 91
Apr 12, 2016: Changes to Getinge Group’s financial reporting 92
Mar 09, 2016: Getinge publishes the Board’s proposal for resolution on the AGM 2016 regarding a long-term incentive program and the adopted performance condition 93
Appendix 94
Methodology 94
About GlobalData 94
Contact Us 94
Disclaimer 94

List of Tables
Getinge AB, Medical Equipment, Key Facts, 2016 2
Getinge AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Getinge AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Getinge AB, Medical Equipment Deals By Type, 2011 to YTD 2017 9
Getinge AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Getinge AB, Deals By Market, 2011 to YTD 2017 11
Getinge AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Kinetic Concepts Completes Sale Of Therapeutic Support Systems Business To Getinge For US$275 Million 14
Maquet Cardiopulmonary Completes Acquisition Of Avalon Elite Bi-Caval Dual Lumen Catheter And Vascular Access Kits From Avalon Labs For US$9.5 Million 16
Getinge Enters into Co-Development Agreement with Verb Surgical 18
Getinge Enters into Co-Distribution Agreement with Contego Medical 19
Getinge Enters into Distribution Agreement with Ultra Clean Systems 20
Maquet Medical Systems Enters into Distribution Agreement with Biotronik 21
Maquet Medical Systems Enters into Distribution Agreement with ReFlow Medical 22
Getinge Infection Control Enters into Distribution Agreement with TSO3 23
Maquet Enters into Co-Development Agreement with GE Healthcare 24
Maquet Medical Systems Enters into Agreement with Flight Medical 25
Maquet Medical Systems Extends Distribution Agreement with ClearFlow 26
Maquet Medical Systems Enters into Distribution Agreement with InterValve 27
Pulsion Enters Into Agreement With Maquet For Eirus Continuous Glucose And Lactate Monitoring Solution 28
Maquet Enters Into Distribution Agreement With Swisstom For Swisstom BB2 29
Proxy Biomedical Enters Into Distribution Agreement With Maquet Vascular Systems 30
Richard Wolf Medical Enters Into Agreement With Maquet For Operating Room Integration Solutions 31
Ossur Enters into Distribution Agreement with ArjoHuntleigh 32
Soma Technology Enters Into Agreement With Maquet 33
Maquet Enters Into Co-Marketing Agreement With Aesculap For OR Integration Solutions 34
Maquet Enters Into Technology Integration Agreement With Richard Wolf 35
Siemens Healthcare Enters Into Technology Integration Agreement With MAQUET For Hybrid OR 36
Novadaq Technologies Enters Into Distribution Agreement With MAQUET Cardiovascular 37
StaminaLift Enters into Distribution Agreement with ArjoHuntleigh 38
Getinge Raises USD533.4 Million in Rights Offering of Shares 39
Getinge Completes Public Offering Of Floating Rate Notes For US$140 Million 41
Getinge Acquires Cetrea 42
Getinge Plans to Acquire Additional Stake in Pulsion Medical Systems 43
Getinge Completes Acquisition Of 78.55% Stake In Pulsion Medical Systems For US$148.5 Million 44
Maquet Cardiovascular Acquires LAAx, Developer Of Cardiovascular Surgery Device 46
ArjoHuntleigh Completes Acquisition of Acare Medical Science for USD25.6 Million 47
MAQUET Cardiovascular Completes Acquisition Of Atrium Medical For US$680 Million 48
Getinge AB, Key Competitors 49
Getinge AB, Key Employees 50
Getinge AB, Other Locations 51
Getinge AB, Subsidiaries 52

★海外企業調査レポート[Getinge AB (GETI B)-医療機器分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Canadian Tire Corp Ltd (CTC.A)：企業の財務・戦略的SWOT分析
    Canadian Tire Corp Ltd (CTC.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Sierra Oncology Inc (SRRA)：医療機器：M&Aディール及び事業提携情報
    Summary Sierra Oncology Inc (Sierra Oncology), formerly ProNAi Therapeutics Inc is a clinical stage drug development company that develops and commercializes DNA damage response therapeutics for the treatment of cancer. The company’s product candidate includes SRA737, an orally bioavailable small mo …
  • Corgenix Medical Corp：医療機器：M&Aディール及び事業提携情報
    Summary Corgenix Medical Corp (Corgenix), a subsidiary of Orgentec Diagnostika GmbH is a medical device company that offers medical diagnostic solutions. The company offers vascular disease products, infectious disease products, non-invasive liver biomarkers, and instrumentation. It offers an instru …
  • First Abu Dhabi Bank (FAB)：企業の財務・戦略的SWOT分析
    First Abu Dhabi Bank (FAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Lund University-製薬・医療分野：企業M&A・提携分析
    Summary Lund University (LNU) is an educational service provider that offers master and bachelor programmes. It offers education and research in the areas of engineering, economics and management, science, law, social sciences, medicine, humanities, theology, fine art, music and others. The universi …
  • vTv Therapeutics Inc (VTVT)：製薬・医療：M&Aディール及び事業提携情報
    Summary vTv Therapeutics Inc (vTv), formerly TransTech Inc, is a pharmaceutical company that discovers, develops and commercializes human therapeutics. The company offers a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of human diseases includ …
  • Ingram Micro Inc：企業の戦略的SWOT分析
    Ingram Micro Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Stereotaxis Inc (STXS)：製薬・医療：M&Aディール及び事業提携情報
    Summary Stereotaxis Inc (Stereotaxis) designs, manufactures and markets robotic systems and instruments for electrophysiologists for the treatment of cardiac arrhythmias. Its flagship product, Epoch solution is an advanced remote robotic navigation system for use in interventional lab for the treatm …
  • Kayne Anderson MLP Investment Company：企業のM&A・事業提携・投資動向
    Kayne Anderson MLP Investment Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kayne Anderson MLP Investment Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • PEPKOR RETAIL LIMITED：企業の戦略・SWOT・財務分析
    PEPKOR RETAIL LIMITED - Strategy, SWOT and Corporate Finance Report Summary PEPKOR RETAIL LIMITED - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Crown Point Energy Inc (CWV)：石油・ガス：M&Aディール及び事業提携情報
    Summary Crown Point Energy Inc (Crown Point), formerly Crown Point Ventures is an oil and gas company that offers oil and gas development and exploration services. The company acquires and produces crude oil and natural gas deposits. It holds interests in Cerro de Los Leones exploration concessions …
  • FactSet Research Systems Inc. (FDS)：企業の財務・戦略的SWOT分析
    FactSet Research Systems Inc. (FDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Nippon Sheet Glass Company Limited ：企業の戦略・SWOT・財務情報
    Nippon Sheet Glass Company Limited - Strategy, SWOT and Corporate Finance Report Summary Nippon Sheet Glass Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Natural Beauty Bio-Technology Ltd.：戦略・SWOT・企業財務分析
    Natural Beauty Bio-Technology Ltd. - Strategy, SWOT and Corporate Finance Report Summary Natural Beauty Bio-Technology Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • TPG Telecom Ltd (TPM)：企業の財務・戦略的SWOT分析
    TPG Telecom Ltd (TPM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • United Networks Ltd (UNL)：企業の財務・戦略的SWOT分析
    United Networks Ltd (UNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Edinburgh Molecular Imaging Ltd：医療機器：M&Aディール及び事業提携情報
    Summary Edinburgh Molecular Imaging Ltd (EM Imaging) is a biotechnology company that develops optical molecular imaging technology. The company offers discovery and development of small molecules and peptides. It designs agents to improve the diagnosis and treatment of cancer and lung diseases. EM I …
  • Valbiotis SAS (ALVAL)：製薬・医療：M&Aディール及び事業提携情報
    Summary Valbiotis SAS (Valbiotis) is a biotechnology company that develops novel solutions to help prevent cardiometabolic diseases, besides nutrition products. It develops solutions to prevent type 2 diabetes, non-alcoholic steatohepatitis (NASH), obesity and cardiovascular diseases. The company ha …
  • Covance Inc：企業の戦略的SWOT分析
    Covance Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • ArQule Inc (ARQL)：製薬・医療：M&Aディール及び事業提携情報
    Summary ArQule Inc (ArQule) is a development stage clinical biotechnology company. It carries out discovery and development of next-generation, small molecule therapeutics for the treatment of various types of cancer. ArQule develops its oncology product candidates through novel approaches including …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆